Pharmaceutical companies earnestly aiming to launch first generic versions

Published: 2003-12-22 07:00:00

Updated: 2003-12-22 07:00:00

Pharmaceutical business source said that domestic leading major pharmaceutical firms are rushing to introduce the firs generic versions of major soon-to-be-expired drugs with hope of acquiring large share of the patented drugs' market, as the combined market size of glimepiride, risperidone, topi...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK